rs184684058

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2

The NM_000719.7(CACNA1C):​c.2766G>A​(p.Pro922Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000159 in 1,612,976 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00049 ( 2 hom., cov: 32)
Exomes 𝑓: 0.00012 ( 0 hom. )

Consequence

CACNA1C
NM_000719.7 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: -6.76

Publications

1 publications found
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
CACNA1C Gene-Disease associations (from GenCC):
  • Timothy syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • long QT syndrome
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • long QT syndrome 8
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • Brugada syndrome
    Inheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: Orphanet, ClinGen
  • Brugada syndrome 3
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • short QT syndrome
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 12-2595976-G-A is Benign according to our data. Variant chr12-2595976-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 195467.
BP7
Synonymous conserved (PhyloP=-6.76 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000493 (75/152170) while in subpopulation AFR AF = 0.00169 (70/41532). AF 95% confidence interval is 0.00137. There are 2 homozygotes in GnomAd4. There are 36 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 75 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1CNM_000719.7 linkc.2766G>A p.Pro922Pro synonymous_variant Exon 20 of 47 ENST00000399655.6 NP_000710.5
CACNA1CNM_001167623.2 linkc.2766G>A p.Pro922Pro synonymous_variant Exon 20 of 47 ENST00000399603.6 NP_001161095.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1CENST00000399603.6 linkc.2766G>A p.Pro922Pro synonymous_variant Exon 20 of 47 5 NM_001167623.2 ENSP00000382512.1
CACNA1CENST00000399655.6 linkc.2766G>A p.Pro922Pro synonymous_variant Exon 20 of 47 1 NM_000719.7 ENSP00000382563.1
CACNA1CENST00000682544.1 linkc.2856G>A p.Pro952Pro synonymous_variant Exon 20 of 50 ENSP00000507184.1
CACNA1CENST00000406454.8 linkc.2766G>A p.Pro922Pro synonymous_variant Exon 20 of 48 5 ENSP00000385896.3
CACNA1CENST00000399634.6 linkc.2766G>A p.Pro922Pro synonymous_variant Exon 20 of 47 5 ENSP00000382542.2
CACNA1CENST00000683824.1 linkc.2931G>A p.Pro977Pro synonymous_variant Exon 21 of 48 ENSP00000507867.1
CACNA1CENST00000347598.9 linkc.2766G>A p.Pro922Pro synonymous_variant Exon 20 of 49 1 ENSP00000266376.6
CACNA1CENST00000344100.7 linkc.2766G>A p.Pro922Pro synonymous_variant Exon 20 of 47 1 ENSP00000341092.3
CACNA1CENST00000327702.12 linkc.2766G>A p.Pro922Pro synonymous_variant Exon 20 of 48 1 ENSP00000329877.7
CACNA1CENST00000399617.6 linkc.2766G>A p.Pro922Pro synonymous_variant Exon 20 of 48 5 ENSP00000382526.1
CACNA1CENST00000682462.1 linkc.2856G>A p.Pro952Pro synonymous_variant Exon 20 of 47 ENSP00000507105.1
CACNA1CENST00000683781.1 linkc.2856G>A p.Pro952Pro synonymous_variant Exon 20 of 47 ENSP00000507434.1
CACNA1CENST00000683840.1 linkc.2856G>A p.Pro952Pro synonymous_variant Exon 20 of 47 ENSP00000507612.1
CACNA1CENST00000683956.1 linkc.2856G>A p.Pro952Pro synonymous_variant Exon 20 of 47 ENSP00000506882.1
CACNA1CENST00000399638.5 linkc.2766G>A p.Pro922Pro synonymous_variant Exon 20 of 48 1 ENSP00000382547.1
CACNA1CENST00000335762.10 linkc.2841G>A p.Pro947Pro synonymous_variant Exon 21 of 48 5 ENSP00000336982.5
CACNA1CENST00000399606.5 linkc.2766G>A p.Pro922Pro synonymous_variant Exon 20 of 48 1 ENSP00000382515.1
CACNA1CENST00000399621.5 linkc.2766G>A p.Pro922Pro synonymous_variant Exon 20 of 47 1 ENSP00000382530.1
CACNA1CENST00000399637.5 linkc.2766G>A p.Pro922Pro synonymous_variant Exon 20 of 47 1 ENSP00000382546.1
CACNA1CENST00000402845.7 linkc.2766G>A p.Pro922Pro synonymous_variant Exon 20 of 47 1 ENSP00000385724.3
CACNA1CENST00000399629.5 linkc.2766G>A p.Pro922Pro synonymous_variant Exon 20 of 47 1 ENSP00000382537.1
CACNA1CENST00000682336.1 linkc.2841G>A p.Pro947Pro synonymous_variant Exon 21 of 47 ENSP00000507898.1
CACNA1CENST00000399591.5 linkc.2766G>A p.Pro922Pro synonymous_variant Exon 20 of 46 1 ENSP00000382500.1
CACNA1CENST00000399595.5 linkc.2766G>A p.Pro922Pro synonymous_variant Exon 20 of 46 1 ENSP00000382504.1
CACNA1CENST00000399649.5 linkc.2766G>A p.Pro922Pro synonymous_variant Exon 20 of 46 1 ENSP00000382557.1
CACNA1CENST00000399597.5 linkc.2766G>A p.Pro922Pro synonymous_variant Exon 20 of 47 1 ENSP00000382506.1
CACNA1CENST00000399601.5 linkc.2766G>A p.Pro922Pro synonymous_variant Exon 20 of 47 1 ENSP00000382510.1
CACNA1CENST00000399641.6 linkc.2766G>A p.Pro922Pro synonymous_variant Exon 20 of 47 1 ENSP00000382549.1
CACNA1CENST00000399644.5 linkc.2766G>A p.Pro922Pro synonymous_variant Exon 20 of 47 1 ENSP00000382552.1
CACNA1CENST00000682835.1 linkc.2766G>A p.Pro922Pro synonymous_variant Exon 20 of 47 ENSP00000507282.1
CACNA1CENST00000683482.1 linkc.2757G>A p.Pro919Pro synonymous_variant Exon 20 of 47 ENSP00000507169.1
CACNA1CENST00000682686.1 linkc.2766G>A p.Pro922Pro synonymous_variant Exon 20 of 46 ENSP00000507309.1
CACNA1CENST00000480911.6 linkn.*1373G>A non_coding_transcript_exon_variant Exon 18 of 27 5 ENSP00000437936.2
CACNA1CENST00000480911.6 linkn.*1373G>A 3_prime_UTR_variant Exon 18 of 27 5 ENSP00000437936.2

Frequencies

GnomAD3 genomes
AF:
0.000427
AC:
65
AN:
152052
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00145
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000205
AC:
51
AN:
248640
AF XY:
0.000185
show subpopulations
Gnomad AFR exome
AF:
0.00168
Gnomad AMR exome
AF:
0.000291
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000124
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000125
AC:
182
AN:
1460806
Hom.:
0
Cov.:
31
AF XY:
0.000116
AC XY:
84
AN XY:
726680
show subpopulations
African (AFR)
AF:
0.00200
AC:
67
AN:
33454
American (AMR)
AF:
0.000425
AC:
19
AN:
44678
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26120
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39682
South Asian (SAS)
AF:
0.0000464
AC:
4
AN:
86144
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53146
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000747
AC:
83
AN:
1111464
Other (OTH)
AF:
0.000116
AC:
7
AN:
60350
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
9
18
26
35
44
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000493
AC:
75
AN:
152170
Hom.:
2
Cov.:
32
AF XY:
0.000484
AC XY:
36
AN XY:
74420
show subpopulations
African (AFR)
AF:
0.00169
AC:
70
AN:
41532
American (AMR)
AF:
0.000196
AC:
3
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4804
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
67980
Other (OTH)
AF:
0.00
AC:
0
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.517
Heterozygous variant carriers
0
3
7
10
14
17
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000334
Hom.:
0
Bravo
AF:
0.000514
Asia WGS
AF:
0.00202
AC:
7
AN:
3478
EpiCase
AF:
0.000109
EpiControl
AF:
0.00

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 03, 2015
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Long QT syndrome Benign:1
Jan 07, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Sep 06, 2016
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
1.6
DANN
Benign
0.67
PhyloP100
-6.8
Mutation Taster
=78/22
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs184684058; hg19: chr12-2705142; API